CRISPR THERAPEUTIC financial statements, including revenue, expenses, profit, and loss

The total revenue of 1CG for the last quarter is 510.15 k CHF, and it's 9.76% higher compared to the previous quarter. The net income of Q3 24 is -72.83 M CHF.